• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化聚乳酸-羟基乙酸共聚物-聚乙二醇纳米颗粒的大小和分布以增强药物对炎症性肠屏障的靶向作用。

Optimising PLGA-PEG Nanoparticle Size and Distribution for Enhanced Drug Targeting to the Inflamed Intestinal Barrier.

作者信息

Mohan Lauren J, McDonald Lauren, Daly Jacqueline S, Ramtoola Zebunnissa

机构信息

Division of Biology, Department of Anatomy and Regenerative Medicine, RCSI University of Medicine and Health Sciences, Dublin 2 D02 YN77, Ireland.

School of Pharmacy and Biological Sciences, RCSI University of Medicine and Health Sciences, Dublin 2 D02 YN77, Ireland.

出版信息

Pharmaceutics. 2020 Nov 19;12(11):1114. doi: 10.3390/pharmaceutics12111114.

DOI:10.3390/pharmaceutics12111114
PMID:33228175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7699526/
Abstract

Oral nanomedicines are being investigated as an innovative strategy for targeted drug delivery to treat inflammatory bowel diseases. Preclinical studies have shown that nanoparticles (NPs) can preferentially penetrate inflamed intestinal tissues, allowing for targeted drug delivery. NP size is a critical factor affecting their interaction with the inflamed intestinal barrier and this remains poorly defined. In this study we aimed to assess the impact of NP particle size (PS) and polydispersity (PDI) on cell interaction and uptake in an inflamed epithelial cell model. Using 10, 55 and 100 mg/mL poly(lactic-co-glycolic acid)-polyethylene glycol (PLGA-PEG), NPs of 131, 312 and 630 nm PS, respectively, were formulated by solvent dispersion. NP recovery was optimised by differential centrifugation to yield NPs of decreased and unimodal size distribution. NP-cell interaction was assessed in healthy and inflamed caco-2 cell monolayers. Results show that NP interaction with caco-2 cells increased with increasing PS and PDI and was significantly enhanced in inflamed cells. Trypan blue quenching revealed that a significant proportion of multimodal NPs were primarily membrane bound, while monomodal NPs were internalized within cells. These results are interesting as the PS and PDI of NPs can be optimised to allow targeting of therapeutic agents to the epithelial membrane and/or intracellular targets in the inflamed intestinal epithelium.

摘要

口服纳米药物正作为一种靶向给药的创新策略进行研究,用于治疗炎症性肠病。临床前研究表明,纳米颗粒(NPs)能够优先穿透发炎的肠道组织,实现靶向给药。NP大小是影响其与发炎肠道屏障相互作用的关键因素,而这一点仍未明确界定。在本研究中,我们旨在评估NP粒径(PS)和多分散性(PDI)对发炎上皮细胞模型中细胞相互作用和摄取的影响。使用10、55和100mg/mL的聚乳酸-乙醇酸-聚乙二醇(PLGA-PEG),分别通过溶剂分散法制备了PS为131、312和630nm的NPs。通过差速离心优化NP回收率,以获得粒径减小且单峰分布的NPs。在健康和发炎的caco-2细胞单层中评估NP-细胞相互作用。结果表明,NP与caco-2细胞的相互作用随着PS和PDI的增加而增强,并且在发炎细胞中显著增强。台盼蓝淬灭显示,相当一部分多峰NP主要与膜结合,而单峰NP则被细胞内化。这些结果很有意思,因为可以优化NP的PS和PDI,使治疗剂能够靶向发炎肠道上皮中的上皮膜和/或细胞内靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/c31816533d55/pharmaceutics-12-01114-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/ac742e5635e9/pharmaceutics-12-01114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/0b1990ddee08/pharmaceutics-12-01114-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/d202e3a38960/pharmaceutics-12-01114-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/45983f71ea29/pharmaceutics-12-01114-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/769f5996553c/pharmaceutics-12-01114-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/68bdb9a7c6bf/pharmaceutics-12-01114-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/8dc7d875831c/pharmaceutics-12-01114-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/c31816533d55/pharmaceutics-12-01114-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/ac742e5635e9/pharmaceutics-12-01114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/0b1990ddee08/pharmaceutics-12-01114-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/d202e3a38960/pharmaceutics-12-01114-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/45983f71ea29/pharmaceutics-12-01114-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/769f5996553c/pharmaceutics-12-01114-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/68bdb9a7c6bf/pharmaceutics-12-01114-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/8dc7d875831c/pharmaceutics-12-01114-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7549/7699526/c31816533d55/pharmaceutics-12-01114-g008.jpg

相似文献

1
Optimising PLGA-PEG Nanoparticle Size and Distribution for Enhanced Drug Targeting to the Inflamed Intestinal Barrier.优化聚乳酸-羟基乙酸共聚物-聚乙二醇纳米颗粒的大小和分布以增强药物对炎症性肠屏障的靶向作用。
Pharmaceutics. 2020 Nov 19;12(11):1114. doi: 10.3390/pharmaceutics12111114.
2
Oral infliximab nanomedicines for targeted treatment of inflammatory bowel diseases.口服英夫利昔单抗纳米药物靶向治疗炎症性肠病。
Eur J Pharm Sci. 2023 Apr 1;183:106379. doi: 10.1016/j.ejps.2023.106379. Epub 2023 Jan 13.
3
PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.聚乙二醇功能化微粒可选择性靶向炎症性肠病中的炎症黏膜。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):578-86. doi: 10.1016/j.ejpb.2013.09.016. Epub 2013 Sep 29.
4
Novel polyurethane-based nanoparticles of infliximab to reduce inflammation in an in-vitro intestinal epithelial barrier model.新型英夫利昔单抗聚氨酯纳米颗粒可减少体外肠上皮屏障模型中的炎症反应。
Int J Pharm. 2019 Jun 30;565:533-542. doi: 10.1016/j.ijpharm.2019.05.025. Epub 2019 May 11.
5
Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer.聚乳酸-羟基乙酸共聚物修饰的纳米颗粒在宫颈癌中的摄取和转运增强
J Nanobiotechnology. 2016 Apr 22;14:33. doi: 10.1186/s12951-016-0185-x.
6
Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.聚(乳酸-共-乙醇酸)纳米粒的聚乙二醇化程度对增强洛哌丁胺中枢神经系统递送的比较评价。
J Pharm Pharmacol. 2013 Oct;65(10):1473-81. doi: 10.1111/jphp.12125. Epub 2013 Aug 1.
7
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.用于多西他赛口服递送的聚丙交酯-维生素E衍生物/蒙脱石纳米颗粒制剂
Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.
8
Noncovalent PEG Coating of Nanoparticle Drug Carriers Improves the Local Pharmacokinetics of Rectal Anti-HIV Microbicides.非共价 PEG 涂层纳米药物载体可改善直肠抗 HIV 微凝胶的局部药代动力学。
ACS Appl Mater Interfaces. 2018 Oct 17;10(41):34942-34953. doi: 10.1021/acsami.8b12214. Epub 2018 Oct 4.
9
The effect of poly(ethylene glycol) coating and monomer type on poly(alkyl cyanoacrylate) nanoparticle interactions with lipid monolayers and cells.聚乙二醇涂层和单体类型对聚氰基丙烯酸烷基酯纳米颗粒与脂质单层及细胞相互作用的影响。
Colloids Surf B Biointerfaces. 2017 Feb 1;150:373-383. doi: 10.1016/j.colsurfb.2016.10.051. Epub 2016 Oct 31.
10
Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.载有吉非替尼的均匀羧甲基壳聚糖包裹的普朗尼克 F68/聚乳酸-羟基乙酸共聚物纳米载体,用于促进难溶性抗肿瘤化合物吉非替尼的口服递送。
Colloids Surf B Biointerfaces. 2019 May 1;177:425-432. doi: 10.1016/j.colsurfb.2019.02.028. Epub 2019 Feb 15.

引用本文的文献

1
Therapeutic potential of betaine and its derivatives in cancer treatment: a comprehensive review.甜菜碱及其衍生物在癌症治疗中的治疗潜力:综述
RSC Adv. 2025 Jun 17;15(26):20605-20622. doi: 10.1039/d5ra00755k. eCollection 2025 Jun 16.
2
Enhanced Mucoadhesion of Thiolated β-Cyclodextrin by S-Protection with 2-Mercaptoethanesulfonic Acid.通过用2-巯基乙烷磺酸进行S-保护增强硫醇化β-环糊精的粘膜粘附性。
ACS Omega. 2024 Jan 26;9(5):5819-5828. doi: 10.1021/acsomega.3c08836. eCollection 2024 Feb 6.
3
Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions.

本文引用的文献

1
Novel polyurethane-based nanoparticles of infliximab to reduce inflammation in an in-vitro intestinal epithelial barrier model.新型英夫利昔单抗聚氨酯纳米颗粒可减少体外肠上皮屏障模型中的炎症反应。
Int J Pharm. 2019 Jun 30;565:533-542. doi: 10.1016/j.ijpharm.2019.05.025. Epub 2019 May 11.
2
The future of nanomedicine in optimising the treatment of inflammatory bowel disease.纳米医学在优化炎症性肠病治疗方面的未来。
Scand J Gastroenterol. 2019 Jan;54(1):18-26. doi: 10.1080/00365521.2018.1563805. Epub 2019 Jan 24.
3
Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells.
纳米治疗学的异质性:来源、影响与解决方案。
Small. 2024 Apr;20(17):e2307502. doi: 10.1002/smll.202307502. Epub 2023 Dec 5.
4
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation.聚乳酸-乙醇酸纳米和微粒在递送调节炎症不同阶段的药物中的应用。
Pharmaceutics. 2023 Jun 20;15(6):1772. doi: 10.3390/pharmaceutics15061772.
5
Design and Development of Levodopa Loaded Polymeric Nanoparticles for Intranasal Delivery.用于鼻内给药的左旋多巴负载型聚合物纳米颗粒的设计与开发
Pharmaceuticals (Basel). 2022 Mar 18;15(3):370. doi: 10.3390/ph15030370.
6
PLGA/PEG Nanoparticles Loaded with Cyclodextrin- Alkaloid Complex and Ascorbic Acid with Promising Antimicrobial Activities.负载环糊精 - 生物碱复合物和抗坏血酸且具有良好抗菌活性的聚乳酸 - 羟基乙酸共聚物/聚乙二醇纳米颗粒
Pharmaceutics. 2022 Jan 7;14(1):142. doi: 10.3390/pharmaceutics14010142.
7
A Novel Sustained Anti-Inflammatory Effect of Atorvastatin-Calcium PLGA Nanoparticles: In Vitro Optimization and In Vivo Evaluation.阿托伐他汀钙聚乳酸-羟基乙酸共聚物纳米粒的新型持续抗炎作用:体外优化与体内评价
Pharmaceutics. 2021 Oct 11;13(10):1658. doi: 10.3390/pharmaceutics13101658.
PLGA-PEG 纳米粒的形貌依赖性人细胞毒性。
Sci Rep. 2017 Aug 4;7(1):7315. doi: 10.1038/s41598-017-07588-9.
4
Enhanced Uptake of Fe₃O₄ Nanoparticles by Intestinal Epithelial Cells in a State of Inflammation.炎症状态下肠上皮细胞对Fe₃O₄纳米颗粒摄取的增强
Molecules. 2017 Jul 27;22(8):1240. doi: 10.3390/molecules22081240.
5
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.用于静脉注射的载多西他赛聚乳酸-羟基乙酸共聚物和聚乳酸-羟基乙酸共聚物-聚乙二醇纳米粒:药代动力学和生物分布特征
Int J Nanomedicine. 2017 Jan 27;12:935-947. doi: 10.2147/IJN.S121881. eCollection 2017.
6
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease.口服细胞特异性纳米疗法治疗炎症性肠病的最新进展
World J Gastroenterol. 2016 Sep 14;22(34):7718-26. doi: 10.3748/wjg.v22.i34.7718.
7
Purification of Nanoparticles by Size and Shape.按尺寸和形状对纳米颗粒进行纯化
Sci Rep. 2016 Jun 8;6:27494. doi: 10.1038/srep27494.
8
Where Are We Heading in Nanotechnology Environmental Health and Safety and Materials Characterization?纳米技术的环境健康与安全以及材料表征将何去何从?
ACS Nano. 2015 Jun 23;9(6):5627-30. doi: 10.1021/acsnano.5b03496.
9
Separation of monodisperse alginate nanoparticles and effect of particle size on transport of vitamin E.单分散海藻酸钠纳米粒子的分离及其粒径对维生素 E 传递的影响。
Carbohydr Polym. 2015 Jun 25;124:274-9. doi: 10.1016/j.carbpol.2015.02.007. Epub 2015 Feb 14.
10
The epidemiology of inflammatory bowel disease.炎症性肠病的流行病学
Scand J Gastroenterol. 2015 Aug;50(8):942-51. doi: 10.3109/00365521.2015.1014407. Epub 2015 Feb 17.